Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optoacoustic Detection of Inflammation Using MSOT Device

NCT: NCT05333978 · TERMINATED

NCT IDNCT05333978
StatusTERMINATED
Start Date2022-05-31
Completion2026-04-20
SponsorUniversity of Oklahoma (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the safety and potential of a new experimental imaging instrument called multispectral optoacoustic tomography (MSOT) to detect inflammation in patients with chronic graft versus host disease of the skin or GI tract, Crohn's disease, or Colitis disease.

Frequently Asked Questions

What is Optoacoustic Detection of Inflammation Using MSOT Device?

Optoacoustic Detection of Inflammation Using MSOT Device is a clinical trial registered under NCT05333978. Current status: TERMINATED.

What is the status of NCT05333978?

The current status of NCT05333978 (Optoacoustic Detection of Inflammation Using MSOT Device) is: TERMINATED.

When did Optoacoustic Detection of Inflammation Using MSOT Device start?

Optoacoustic Detection of Inflammation Using MSOT Device started on 2022-05-31.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.